Brain changes responsible for the appetite effects of cannabis identified
New research on how cannabis use alters eating behaviour could lead to treatments for appetite loss in chronic illness...
List view / Grid view
New research on how cannabis use alters eating behaviour could lead to treatments for appetite loss in chronic illness...
The new centre will serve as one of the world’s leading institutes for conducting and coordinating research about cannabinoids, endocannabinoids and medical Cannabis. In addition, it will promote collaboration and disseminate information.
Cannabidiol shown to affect emotion and emotional memory
Medicinal marijuana is used frequently as a painkiller for a variety of ailments and diseases yet its psycho active side effects are seen by many as a significant disadvantage.
Fibromyalgia (FM) has been described as a condition of heightened generalised sensitisation to sensory input presenting as a complex of symptoms dominated by chronic widespread pain characterised by hyperalgesia and allodynia. A range of co-morbidities of variable intensity, such as fatigue, sleep disturbance, cognitive impairment, anxiety and depression, are often…
24 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Drug Target Review caught up with Dr Brian Murphy, CEO and Chief Medical Officer of Nemus Bioscience, to find out the latest in cannabinoid research…
10 August 2016 | By Niamh Louise Marriott, Digital Content Producer
The company 's intends to develop the most effective cannabis strains specific to pain, nausea, epilepsy and PTSD, solving the critical need for real science to support medical marijuana claims...
11 August 2014 | By B3C newswire
FAAH Pharma Inc., announced an investment by TVM Life Science Ventures VII investment into the company.